HC Wainwright & Co. Maintains Buy on Panbela Therapeutics, Lowers Price Target to $5

Moomoo 24/7 ·  Apr 2 08:49

HC Wainwright & Co. analyst Joseph Pantginis maintains Panbela Therapeutics (OTC:PBLA) with a Buy and lowers the price target from $16 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment